These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29416802)

  • 1. Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.
    Gibbs LD; Vishwanatha JK
    Oncotarget; 2018 Jan; 9(2):2697-2704. PubMed ID: 29416802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis.
    Chaudhary P; Gibbs LD; Maji S; Lewis CM; Suzuki S; Vishwanatha JK
    Breast Cancer Res; 2020 Jan; 22(1):11. PubMed ID: 31992335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANXA2 expression in African American triple-negative breast cancer patients.
    Gibbs LD; Chaudhary P; Mansheim K; Hare RJ; Mantsch RA; Vishwanatha JK
    Breast Cancer Res Treat; 2019 Feb; 174(1):113-120. PubMed ID: 30478786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cells.
    Koh M; Lim H; Jin H; Kim M; Hong Y; Hwang YK; Woo Y; Kim ES; Kim SY; Kim KM; Lim HK; Jung J; Kang S; Park B; Lee HB; Han W; Lee MS; Moon A
    Autophagy; 2024 Mar; 20(3):659-674. PubMed ID: 38290972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance of Annexin A2 Expression in Breast Cancer Patients.
    Gibbs LD; Mansheim K; Maji S; Nandy R; Lewis CM; Vishwanatha JK; Chaudhary P
    Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis.
    Okano M; Oshi M; Butash AL; Katsuta E; Tachibana K; Saito K; Okayama H; Peng X; Yan L; Kono K; Ohtake T; Takabe K
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31461932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.
    Sobral-Leite M; Wesseling J; Smit VT; Nevanlinna H; van Miltenburg MH; Sanders J; Hofland I; Blows FM; Coulson P; Patrycja G; Schellens JH; Fagerholm R; Heikkilä P; Aittomäki K; Blomqvist C; Provenzano E; Ali HR; Figueroa J; Sherman M; Lissowska J; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Phillips KA; ; Couch FJ; Olson JE; Vachon C; Visscher D; Brenner H; Butterbach K; Arndt V; Holleczek B; Hooning MJ; Hollestelle A; Martens JW; van Deurzen CH; van de Water B; Broeks A; Chang-Claude J; Chenevix-Trench G; Easton DF; Pharoah PD; García-Closas M; de Graauw M; Schmidt MK
    BMC Med; 2015 Jul; 13():156. PubMed ID: 26137966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of annexin A family in glioblastoma.
    Xu H; Wu X; Dou Y; Zheng W
    Ir J Med Sci; 2022 Aug; 191(4):1539-1547. PubMed ID: 34398393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of annexin A1 expression in breast cancer.
    Yom CK; Han W; Kim SW; Kim HS; Shin HC; Chang JN; Koo M; Noh DY; Moon BI
    J Breast Cancer; 2011 Dec; 14(4):262-8. PubMed ID: 22323911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cell-Based Systematic Review on the Role of Annexin A1 in Triple-Negative Breast Cancers.
    Pearanpan L; Nordin FJ; Siew EL; Kumolosasi E; Mohamad Hanif EA; Masre SF; Chua EW; Cheng HS; Rajab NF
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
    Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
    Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression.
    Reyes ME; Fujii T; Branstetter D; Krishnamurthy S; Masuda H; Wang X; Reuben JM; Woodward WA; Edwards BJ; Hortobagyi GN; Tripathy D; Dougall WC; Eckhardt BL; Ueno NT
    Breast Cancer Res Treat; 2017 Jul; 164(1):57-67. PubMed ID: 28417335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients.
    Pedersen MH; Hood BL; Ehmsen S; Beck HC; Conrads TP; Bak M; Ditzel HJ; Leth-Larsen R
    Int J Cancer; 2019 Feb; 144(3):631-640. PubMed ID: 30110125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis.
    Gao G; Wang Z; Qu X; Zhang Z
    BMC Cancer; 2020 Mar; 20(1):179. PubMed ID: 32131780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Small Extracellular Vesicle-Derived Annexin A2 Protein and mRNA as a Potential Predictive Biomarker for Chemotherapy Responsiveness in Aggressive Triple-Negative Breast Cancer.
    Desai PP; Narra K; James JD; Jones HP; Tripathi AK; Vishwanatha JK
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of ANXA2 predicts adverse outcomes of patients with malignant tumors: a systematic review and meta-analysis.
    Liu X; Ma D; Jing X; Wang B; Yang W; Qiu W
    Med Oncol; 2015 Jan; 32(1):392. PubMed ID: 25476478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer.
    Choi CH; Chung JY; Chung EJ; Sears JD; Lee JW; Bae DS; Hewitt SM
    BMC Cancer; 2016 Jul; 16():448. PubMed ID: 27402115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.
    Miyashita M; Sasano H; Tamaki K; Hirakawa H; Takahashi Y; Nakagawa S; Watanabe G; Tada H; Suzuki A; Ohuchi N; Ishida T
    Breast Cancer Res; 2015 Sep; 17(1):124. PubMed ID: 26341640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of sonographic features and molecular subtypes in predicting breast cancer disease outcomes.
    Wang H; Yao J; Zhu Y; Zhan W; Chen X; Shen K
    Cancer Med; 2020 Sep; 9(17):6173-6185. PubMed ID: 32657039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC).
    Ma F; Li H; Li Y; Ding X; Wang H; Fan Y; Lin C; Qian H; Xu B
    Medicine (Baltimore); 2017 Apr; 96(14):e6561. PubMed ID: 28383433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.